Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Clinical trial NCT01569087 · COMPLETED

Trial details

NCT number: NCT01569087
Sponsor: Biocad
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Neutropenia

Start date: 2012-05-01
Primary completion: 2013-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.